Participants 76 121 4
in HIV-associated B-cell non-Hodgkin lymphoma
Participants 198 261 5
immunocompetent patients with B-cell non-Hodgkin lymphoma (NHL)
Participants 713 731 3
HIV-associated NHL
Participants 956 1023 3
35 of 48 evaluable patients (73%; 95% confidence interval, 58%-85%)
Participants 1072 1139 3
29 of 53 evaluable patients (55%; 95% confidence interval, 41%-68%)
Participants 1479 1502 3
HIV-associated lymphoma
